“Cardiothoracic surgery is 19.57 to 1, and general surgery is 3.4 to 1.”Of course, this is not the case in Korea. These were the competition rates for medical specialties in the U.K. in 2022. Unlike Korea, “vital departments” like cardiothoracic surgery and general surgery are popular among doctors
Handok said it decided to establish a local joint venture with Swedish Orphan Biovitrum (Sobi), a global biopharmaceutical company specializing in rare diseases, in the first half of this year.Sobi is a global biopharmaceutical company specializing in rare diseases, providing innovative treatments i
JW Pharmaceuticals announced on Tuesday that interim results from a study showcasing the efficacy and safety of Hemlibra (emicizumab) in hemophilia A patients younger than one year old were recently published in the international journal Blood.Dr. Steven Pipe, professor of pediatrics at the Universi
It's a new year, the time when many commit to living a healthier life. To succeed, remember this: focus on short-term goals rather than long-term ones. Humans often prioritize immediate benefits over future ones, a phenomenon known as preference reversal over time in behavioral economics.Dermatologi
Hugel said it showcased new clinical findings for its botulinum toxin (BTX) product at the 25th International Master Course on Aging Science (IMCAS) World Congress, held in Paris, France, from Feb. 1 to 3.The event, which is recognized as the world's largest conference on aesthetic plastic surgery,
The Ministry of Health and Welfare has dismissed as untrue claims that the increase in medical school enrollment quotas is for election purposes and that the government and medical community will adjust the size of the increase after the election.The ministry added that the increased medical school
Tevimbra (tislelizumab), an anti-PD-1 immunotherapy developed by BeiGene, has begun the process of seeking reimbursement in Korea.BeiGene's stance of supplying innovative new drugs at reasonable prices is drawing attention to whether it could alleviate the growing financial burden caused by high-pri
Yuhan Corp. will hold its annual shareholders' meeting next month and decide whether to reappoint Cho Wook-je as its president and CEO. Industry officials watch with interest whether Cho will serve another term.The company issued a public notice last Tuesday, announcing that it would hold its annual
Celltrion said it has completed its application for marketing authorization to the European Medicines Agency (EMA) for CT-P47, a biosimilar referencing Actemra.Roche's Actemra (ingredient: tocilizumab), known as RoActemra in Europe, is approved for a wide range of conditions, including rheumatoid ar
A new treatment has landed in Korea for moderate to severe active ulcerative colitis that has not responded adequately to standard treatments or biologics or has become unresponsive.Lilly Korea said Thursday that the interleukin-23 (IL-23) inhibitor Omvoh (mirikizumab) has received approval from the
Severance Hospital has succeeded in conducting Korea's first irreversible electroporation surgery technique on a 76-year-old liver cancer patient. The patient has since been discharged and is now resuming normal daily activities.IRE involves creating small gaps of about 2mm in the cancerous tissue b
Eutilex said Thursday that it has completed registering a patent for antibody therapy, “103,” in China.The patent for “103” was registered as "Anti-Human VSIG4 Antibody and Uses Thereof." Eutilex, which has completed patient registration in the U.S. and Russia, expects to expand its business territo
C-Biomex said Thursday that it has entered into a collaborative research agreement with MD Anderson Cancer Center to proceed with the U.S. investigational new drug (IND) application for its radiopharmaceutical therapy, CBT-001.CBT-001 targets CA-9 (Carbonic anhydrase 9), which is overexpressed in ki
OCI Holdings Chairman Lee Woo-hyun has reaffirmed the company's strategy to play a minimal role in the management of Hanmi Group following the upcoming integration with Hanmi Science.During an investor conference call on Wednesday, Chairman Lee stated that OCI Holdings intends to support Hanmi Group
JW Pharmaceutical has posted record earnings in 2023, driven by increased sales of its hyperlipidemia drugs Livalo (pitavastatin) and LivaloZet and hemophilia drug Hemlibra.JW Pharmaceutical released its preliminary operating results for the past year through a disclosure of changes in sales or prof
Seoul National University Bundang Hospital (SNUBH) said on Thursday that Professor Kim Yeon-wook of the Pulmonology Department has been appointed as a member of the multidisciplinary practice standards committee of the International Association for the Study of Lung Cancer (IASLC). Kim's tenure in t
Yongin Severance Hospital has started prescribing Somzz, the first digital therapeutics (DTx) device in Korea, for older adults with insomnia.Somzz, approved by the Ministry of Food and Drug Safety in February last year, implements cognitive behavioral therapy, the optimum standard treatment for ins
GC Biopharma recorded disappointing results last year due to a decline in Covid-19-related demand and the slowing exports of Hunterase amid rising geopolitical risks.GC Biopharma released its preliminary consolidated operating results for 2023 by disclosing changes in sales or profit and loss struct
Yuhan Corp. said it posted highest-ever annual sales in 2023 thanks to technology export revenue.The company reported consolidated sales and operating profit of 1.8 trillion won ($1.3 billion) and 56.7 billion won in 2023, up 4.7 percent and 57.6 percent year-on-year. Net profit also jumped 57.4 per
The Seoul High Court on Wednesday upheld the lower court's decision, rejecting Kolon Life Science's appeal to suspend the Ministry of Food and Drug Safety's order cancelling the approval for Invossa-K, a gene therapy for osteoarthritis.This decision marks the second defeat for Kolon Life Science in